Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
- First Posted Date
- 2006-09-11
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT00374660
4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures
- First Posted Date
- 2006-08-24
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 138
- Registration Number
- NCT00368472
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
- Conditions
- Parkinson's Disease
- Interventions
- Drug: placebo comparatorDrug: 2 mg perampanelDrug: 4 mg perampanel
- First Posted Date
- 2006-08-24
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 752
- Registration Number
- NCT00368108
- Locations
- 🇺🇸
Lehigh Valley Hospital, Allentown, Pennsylvania, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Ohio State University Medical Center, Columbus, Ohio, United States
A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 997
- Registration Number
- NCT00360412
- Locations
- 🇩🇪
Philipps-University Marburg, Marburg, Germany
Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT00358644
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 1276
- Registration Number
- NCT00337103
- Locations
- 🇧🇪
Institut Jules Bordet, Medical Oncology Unit, Brussels, Belgium
🇦🇺Royal Perth Hospital, Perth, Western Australia, Australia
🇦🇺Bankstown Hospital, Oncology Trials Unit, Bankstown, New South Wales, Australia
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 356
- Registration Number
- NCT00334958
- Locations
- 🇺🇸
University of South Alabama Medical Center, Mobile, Alabama, United States
🇺🇸Bradenton Research Center, Bradenton, Florida, United States
🇺🇸Advocate Hope Children's Hospital, Oak Lawn, Illinois, United States
ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis
- First Posted Date
- 2006-06-08
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT00334828
Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial
- Conditions
- Muscle Spasm; Back Pain
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00327730
- Locations
- 🇮🇳
Grant Medical College Sir J.J. Group of Hospitals, Byculla, Mumbai, Maharashtra, India
🇮🇳L.T. M. Medical College and General Hospital, Sion, Mumbai, Maharashtra, India
🇮🇳M.R. Medical College, Gulbarga, Karnataka, India
A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.
- Conditions
- Procedural Sedation
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT00327392
- Locations
- 🇺🇸
St. Louis Women's Healthcare Group, Chesterfield, Missouri, United States
🇺🇸International Heart Institute of Montana, Missoula, Montana, United States
🇺🇸Southern Orthopaedic Sports Medicine, Columbia, South Carolina, United States